| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/23/2008 | US7468444 Crystalline polymorphic dosage forms of anticholesterol agents; statins; suspending atorvastatin hemi-calcium in water for 16 hours convert the atorvastatin hemi-calcium into Form I |
| 12/23/2008 | US7468440 Malonamides and malonamide derivatives as modulators of chemokine receptor activity |
| 12/23/2008 | US7468439 Alkylene bridged sultam compounds useful as modulators of nuclear hormone receptor function |
| 12/23/2008 | US7468437 useful as neurokinin-1 (NK-1) receptor antagonists, and inhibitors of tachykinin and in particular substance P; treatment of certain disorders, including emesis, depression, and anxiety |
| 12/23/2008 | US7468436 Method of resolution and antiviral activity of 1,3-oxathiolane nucleoside enantiomers |
| 12/23/2008 | US7468428 Lyophilized azithromycin formulation |
| 12/23/2008 | US7468394 Mixing propofol, oil and egg lecithin, adding mixture of water and glycerin; entrapping propofol within shells of liposome particles; emulsification by use of a homogenizer, adjusting final volume and pH,filling, closing and sealing, sterilization, candling, packaging |
| 12/23/2008 | US7468393 Diarylsulfones as 5-HT2A antagonists |
| 12/23/2008 | US7468392 extract isolated from Antrodia camphorata, 4-hydroxy-2,3-dimethoxy-6-methyl-5(3,7,11-trimethyl-dodeca-2,6-10-trienyl)-cyclohex-2-enone, and its use in delaying fatigue |
| 12/23/2008 | US7468391 Methods for treating retinoid responsive disorders using selective inhibitors of CYP26A and CYP26B |
| 12/23/2008 | US7468390 Angiotensin antagonist valsartan and an enkephalinase inhibitor; used to treat cardiovascular disorders |
| 12/23/2008 | US7468389 Cyclopropane carboxylic acid for treatment of nervous system disorders and for slowing metabolism |
| 12/23/2008 | US7468388 Using 5-aceylamino-4-azido-4-nitrophenoxycarbonyloyl) -(2-oxo (1,3-dioxolan-4-yl)-5,6-dihydropyran-2-carxylic acid methyl ester; therapy for myxovirus infections; active materials; stability; long time in lungs |
| 12/23/2008 | US7468387 Crystalline forms of imidoalkanpercarboxylic acids |
| 12/23/2008 | US7468386 Pyrazole-amine compounds for the treatment of neurodegenerative disorders |
| 12/23/2008 | US7468385 Preterm labor, premature birth, dysmenorrhea, inappropriate secretion of vasopressin, congestive heart failure, arterial hypertension, liver cirrhosis, nephrotic syndrome and ocular hypertension; 3-(5-((3-chlorobenzyl)sulfanyl)-4-(3-methoxypropyl)-4H-1,2,4-triazol-3-yl)-N-(2-methoxybenzyl)propanamide |
| 12/23/2008 | US7468384 Microbicidal composition |
| 12/23/2008 | US7468383 Proteasome inhibitors and methods of using the same |
| 12/23/2008 | US7468382 useful for treating a variety of diseases and disorders that are mediated or sustained through the activity of PKC-theta, including immunological disorders and type II diabetes |
| 12/23/2008 | US7468381 Control of arthropods in animals |
| 12/23/2008 | US7468380 Nitrogen-containing aromatic derivatives |
| 12/23/2008 | US7468379 osteoporosis, arthritis, rheumatoid arthritis, cancer metastases to the bone, bone cancer, hypercalcemia, osteolytic lesions with orthopedic implants, Paget's disease, and bone loss associated with hyperparathyroidism |
| 12/23/2008 | US7468378 Substituted quinoline compounds |
| 12/23/2008 | US7468377 Imidazopyridine-derivatives as inductible no-synthase inhibitors |
| 12/23/2008 | US7468376 Pyrazolopyridine derivates |
| 12/23/2008 | US7468375 Inhibitors of the HIV integrase enzyme |
| 12/23/2008 | US7468373 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods |
| 12/23/2008 | US7468372 7-aminosulfonylamino-, aminocarbonylamino- and oxycarbonylamino-substituted pyrrazolo[1,5-a]pyrimidine derivatives, useful in the treatment and prevention of proliferative diseases, for example, cancer, inflammation and arthritis |
| 12/23/2008 | US7468371 Tricyclic pyrazole kinase inhibitors |
| 12/23/2008 | US7468370 [1,7]naphthyridines as PDE4 inhibitors |
| 12/23/2008 | US7468369 Sulfonyl pyrrolidines, method for producing the same and their use as drugs |
| 12/23/2008 | US7468368 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 12/23/2008 | US7468367 depression; anxiety; addictions; obsessive compulsive disorder; affective neurosis/disorder; depressive neurosis/disorder, anxiety neurosis; dysthymic disorder; behaviour disorder; mood disorder; sexual dysfunction; psychosexual dysfunction; sex disorder, sexual disorder; schizophrenia; manic depression; |
| 12/23/2008 | US7468366 Cytotoxic agents |
| 12/23/2008 | US7468365 Lactam compound |
| 12/23/2008 | US7468364 High oral absorption; gramnegative, grampositive bacteria and antibiotic resistant Staphlococcus pneumonia, Hemophilus influenza |
| 12/23/2008 | US7468363 Immunomodulators; side effect reduction; non-Hodgkin's lymphoma, myelogenous leukemia, amyloidosis, and cancer of ovaries, pancreas, kidneys |
| 12/23/2008 | US7468362 Carbonate and carbamate modified forms of glucocorticoids in combination with β2 adrenergic agonists |
| 12/23/2008 | US7468361 For therapy of skin conditions selected from the group consisting of dermatitis, eczema, keratosis, lack of skin firmness, wrinkles, lack of dermal hydration and insufficient sebum secretion |
| 12/23/2008 | US7468360 Therapeutic amides and related compounds |
| 12/23/2008 | US7468359 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
| 12/23/2008 | US7468358 Administering 2-O desulfated heparin or 2-O, 3-O desulfated heparin; does not produce platelet activation in the presence of serum containing HIT antibodies |
| 12/23/2008 | US7468357 Nucleosides with anti-hepatitis B virus activity |
| 12/23/2008 | US7468356 Modulation of insulin like growth factor I receptor expression |
| 12/23/2008 | US7468355 Administering oleuropein |
| 12/23/2008 | US7468210 Immersing the medical device comprising polytetrafluoroethylene in is bis-(benzotriazole carbonate) polyethylene glycol, immersing in crsslinkable chondroitin sulfate, heparan sulfate and heparin bonded to Dodecyldimethylsilylmethyl carbamate compound to provide thromboresistant coating |
| 12/23/2008 | US7468194 Administering liposomes containing povidone iodine for therapy of bacterial infection |
| 12/23/2008 | US7468191 Stability; gas delivery agent used in cosmetic or therapeutic product; mixing fluorocarbon immiscible hydrophilic liquid and a solid emulsifying agent by agitation, adding fluorocarbon, dispersion, gasification |
| 12/23/2008 | US7468179 Aerosol for delivery of naltrexone, buprenorphine, nalbuphine, naloxone, butorphanol, hydromorphone, oxycodone, methadone, remifentanil, sufentanil, or fentanyl by vaporizing the drug, which is coated on support and condensing to form aerosol with mass median aerodynamic diameter of less than 5 microns |
| 12/23/2008 | US7468177 Hydrophilic light absorbing compositions for determination of physiological function in critically ill patients |
| 12/23/2008 | US7468080 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof |
| 12/23/2008 | CA2602643C Composition for improving blood cholesterol levels |
| 12/23/2008 | CA2596497C Nucleotide analog compositions |
| 12/23/2008 | CA2596320C Nucleotide analog compositions |
| 12/23/2008 | CA2560580C Imidazole compounds for inhibition of a.beta.-peptide production and for modulation of the notch signaling pathway |
| 12/23/2008 | CA2490414C Device and method for delivering an oral care agent |
| 12/23/2008 | CA2448058C Pyrazole derivatives as hiv reverse transcriptase inhibitors |
| 12/23/2008 | CA2442557C Dihydro-benzo¬b|¬1,4|diazepin-2-one derivatives as mglur2 antagonists ii |
| 12/23/2008 | CA2426074C Inhalable formulation of a solution containing a tiotropium salt |
| 12/23/2008 | CA2424664C Novel non-imidazole compounds |
| 12/23/2008 | CA2422359C Combretastatin a-4 phosphate prodrug salts with nitrogen-containing compounds |
| 12/23/2008 | CA2419993C Process for preparing pharmaceutical compositions for use with soft gelatin formulations |
| 12/23/2008 | CA2419067C Injectable composition comprising benzimidazole compound and strong alkali |
| 12/23/2008 | CA2387370C Percutaneous sorbefacients for electroporation |
| 12/23/2008 | CA2386627C Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders |
| 12/23/2008 | CA2379003C Therapy of respiratory influenza virus infection using free and liposome-encapsulated ribonucleotides |
| 12/23/2008 | CA2372339C Pharmaceutical product comprising the active substance diamorphine, and its use in a process for treating opiate addiction |
| 12/23/2008 | CA2360676C A method for treating patients with acne by administering a cyclic gmp pde inhibitor |
| 12/23/2008 | CA2348028C Method of preparing delta-9-tetrahydrocannabinol |
| 12/23/2008 | CA2334520C Treatment of immune diseases |
| 12/23/2008 | CA2331685C Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 12/23/2008 | CA2326339C Use of dexmedetomidine for icu sedation |
| 12/23/2008 | CA2319810C Propofol composition containing sulfite |
| 12/23/2008 | CA2314817C Synergistic agents for enhancing tissue repair |
| 12/23/2008 | CA2306393C Use of 11-(3-dimethylaminopropylidene)-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid for the manufacture of a medicament for treating non-allergic ophthalmic inflammatory disorders and for the prevention of ocular neovascularization |
| 12/23/2008 | CA2305799C Composition for the treatment of nicotine addiction containing a nicotine receptor antagonist and an anti-depressant or anti-anxiety drug |
| 12/23/2008 | CA2285298C Complexes comprising local anesthetic and nucleic acid and method of making and using the same |
| 12/23/2008 | CA2284738C Nutritional composition for improvements in cell energetics |
| 12/23/2008 | CA2269334C Therapeutic food composition and method to diminish blood sugar fluctuations |
| 12/23/2008 | CA2263584C Orally applicable formulation of quinolone or naphthyridone carboxylic acids |
| 12/23/2008 | CA2260185C Hormone replacement therapy drug formulations for topical application to the skin |
| 12/23/2008 | CA2249320C Glycosylated humanized b-cell specific antibodies |
| 12/23/2008 | CA2246397C Solid and semi-solid hydrocarbon gels and uses thereof |
| 12/23/2008 | CA2245267C Crystal form of n-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 12/23/2008 | CA2230690C Administration of ketamine to manage pain and to reduce drug dependency |
| 12/23/2008 | CA2214675C Methods and compositions for sedating, anaesthetising and euthanising aquatic organisms |
| 12/23/2008 | CA2187990C Pharmaceutical compositions comprising l-carnitine, or derivative thereof, and trihydroxy or tetrahydroxystilbene |
| 12/23/2008 | CA2178594C Absorption enhancers for topical pharmaceutical formulations |
| 12/23/2008 | CA2175966C Antibacterial oral gel composition for application to dental implant areas |
| 12/23/2008 | CA2158822C Therapeutic agent for rheumatic disease |
| 12/21/2008 | CA2635407A1 An ectoparasiticide composition and a method for exterminating ectoparasites |
| 12/18/2008 | WO2008154601A1 Anti-viral inhibitors and methods of use |
| 12/18/2008 | WO2008154590A2 Predicting responsiveness to temozolomide |
| 12/18/2008 | WO2008154585A1 A drug delivery system for the prevention of cerebral vasospasm |
| 12/18/2008 | WO2008154579A1 Allopregnanolone in a method for enhancing neurological function (alzheimer disease) |
| 12/18/2008 | WO2008154574A1 Method and composition for the treatment of cardiac hypertrophy |
| 12/18/2008 | WO2008154563A1 1, 3 - dihydroxy substituted phenylamide glucokinase activators |
| 12/18/2008 | WO2008154553A1 Method of manufacturing a ruthenium complex |
| 12/18/2008 | WO2008154500A1 Compositions and methods for polymer-caged liposomes |
| 12/18/2008 | WO2008154484A1 Ire-1a inhibitors |